webinar register page

Webinar banner
Challenges of Sepsis Diagnosis: Harnessing the Host Response
This webinar will address the shortcomings of past and current sepsis clinical criteria in accurately capturing patients with critical illness due to infection. The current status of microbiologic methods and single peptide biomarker will be described. A novel approach utilizing the host gene response to infection will be presented.

Staff Physician - Infectious Disease, Beth Israel Lahey Health System
Bio below.

Sepsis Alliance gratefully acknowledges the support provided by this sponsor innovation webinar by Immunexpress.

Mar 31, 2020 02:00 PM in Eastern Time (US and Canada)

Webinar logo
* Required information


Steven P. LaRosa, MD
Staff Physician - Infectious Disease @Beth Israel Lahey Health System
Dr. Steven P. LaRosa graduated from Boston University School of Medicine. He completed his Internal Medicine Residency at the Cleveland Clinic and Infectious Disease Fellowship at Massachusetts General Hospital. He was the lead Clinical Research Physician at Eli Lilly for the PROWESS trial that led to the FDA approval of Xigris for severe sepsis. He returned to academia as the Director of the Ocean State Clinical Coordinating Center at Rhode Island Hospital. In this position he partnered with industry sponsors in clinical development planning, protocol and case report form design, site selection and training, medical monitoring and data review for molecules and devices targeting severe infections. He currently serves on a number of Medical Advisory Boards, Clinical Trial Steering Committees, Endpoint Adjudication Committees and Data Safety Monitoring Boards for experimental agents, devices, and diagnostics in Infectious Disease.